Practical recommendations for screening of information on the drug safety
Abstract
Active development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attracted to the problem of drug safety the attention of practitioners and other health professionals. This article presents practical recommendations on possible sources for screening of information on the drug safety, which can operate in their activity as health professionals.
About the Authors
E. Yu. Pasternak
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
T. M. Bukatina
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
R. N. Alyautdin
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
B. K. Romanov
Scientific Centre for Expert Evaluation of Medicinal Products
Russian Federation
Russian Federation
References
1. Morozova TE, Hoseva EN. Problematic aspects of pharmacovigilance systems in the Russian Federation at the present stage. Good clinical practice 2013, 3: 40–45.
2. Sokova EA. Monitoring the safety of registered medicines in pregnancy: pharmacogenetic aspects. Safety and risk of pharmacotherapy 2015, 3: 30–36.
3. Federal law «On circulation of medicines» ¹ 61-FZ, 22.12.2014 (in Russian).
4. Bukatina TM, Pasternak EYu, Romanov BK, Alyautdin RN, Lepakhin VK, Kazakov AS, Zatolochina KE, Snegireva II, Darmostukova MA, Kolesnikova EYu, Zhuravleva EO, Veltz NYu, Kutekhova GV. Information on the decisions of foreign regulatory. Safety and risk ùà pharmacotherapy 2016, 2: 40–42.
5. Astakhova AV, Lepahin VK, Pereverzev AP. Àrticles as a source to identify adverse drug reactions. Drug safety and pharmacovigilance 2008, 2: 4–12. 2016. ¹ 3 39
6. Astakhova AV. Adverse reactions and drug safety monitoring: Guide to pharmacovigilance. Moscow: Cogito-Center, 2004 (in Russian).
Review
For citations:
Pasternak E.Yu., Bukatina T.M., Alyautdin R.N., Romanov B.K. Practical recommendations for screening of information on the drug safety. Safety and Risk of Pharmacotherapy. 2016;(3):36-39. (In Russ.)
Views:
1199
Email this article 